Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 609 | 133 | 341 | 85 | 0 |
| Gross Profit | 609 | 133 | 341 | 85 | N/A |
| Operating Expenses | 26,489 | 26,469 | 25,019 | 15,414 | 3,381 |
| Operating Income | -25,880 | -26,336 | -24,678 | -15,329 | -3,381 |
| Interest Expense | 1,124 | 502 | 12 | 193 | 184 |
| Other Income | 109 | 89 | 66 | 33 | -43 |
| Pre-tax Income | -26,895 | -26,749 | -24,624 | -15,489 | -3,608 |
| Net Income Continuous | -26,895 | -26,749 | -24,624 | -15,489 | -3,608 |
| Net Income Discontinuous | N/A | 227 | 1,199 | -2,025 | N/A |
| Net Income | $-26,895 | $-26,522 | $-23,425 | $-17,514 | $-3,608 |
| EPS Basic Total Ops | -1.22 | -1.32 | -1.34 | -2.85 | -5.76 |
| EPS Basic Continuous Ops | -1.22 | -1.33 | -1.41 | -2.52 | -5.76 |
| EPS Basic Discontinuous Ops | N/A | 0.01 | 0.07 | -0.33 | N/A |
| EPS Diluted Total Ops | -1.22 | -1.32 | -1.34 | -2.85 | -5.76 |
| EPS Diluted Continuous Ops | -1.22 | -1.33 | -1.41 | -2.52 | -5.76 |
| EPS Diluted Discontinuous Ops | N/A | 0.01 | 0.07 | -0.33 | N/A |
| EPS Diluted Before Non-Recurring Items | -1.22 | -1.33 | -1.41 | -1.97 | -10.80 |
| EBITDA(a) | $-25,600 | $-25,679 | $-23,878 | $-15,005 | $-3,361 |